Drawing for 9METERS BIOPHARMA

USPTO serial 88573419

9METERS BIOPHARMA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
EISNACH, MICHAEL PATRICK
Law office
TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with 9METERS BIOPHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Devon E. White

Devon E. White WYRICK ROBBINS YATES & PONTON LLP4101 LAKE BOONE TRAIL, SUITE 300RALEIGH, NC 27607UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and biological preparations for the treatment of anorectal diseases and gastrointestinal and liver disorders; Targeted pharmacological and biological treatments for anorectal diseases, liver, and gastrointestinal disorders such as fecal incontinence, pruritus ani, and radiation proctitis; Prescription and non-prescription pharmacological and biological treatments administered in various pharmaceutical technological forms, namely, in solid form pills, tablets, capsules, caplets, sachets, in semi-liquid form, namely, gels, ointments and pastes, suppositories, in liquid form, namely, drops, injectables, infusions, in gaseous form, namely, inhalants, or in sprays, namely, intranasally administered medications, for the treatment of anorectal diseases and gastrointestinal illnesses and disorders; Capsules sold empty for pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Suppositories with proprietary delivery system for the precise delivery of drugs that target conditions and diseases of the anorectal region; SuppositoriesACTIVEDec 14, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 17, 2023MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 17, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 17, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 31, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2023CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 20, 2023IUAFUSE AMENDMENT FILED—
Feb 20, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 13, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 12, 2022EX5GSOU EXTENSION 5 GRANTED—
Aug 4, 2022EXT5SOU EXTENSION 5 FILED—
Aug 4, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 5, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 5, 2022NOACCORRECTED NOA E-MAILED—
Mar 4, 2022EX4GSOU EXTENSION 4 GRANTED—
Mar 4, 2022DPCCDIVISIONAL PROCESSING COMPLETE—
Feb 28, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 11, 2022EXT4SOU EXTENSION 4 FILED—
Feb 11, 2022DRRRDIVISIONAL REQUEST RECEIVED—
Feb 11, 2022ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Feb 11, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 22, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 20, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 18, 2021EX3GSOU EXTENSION 3 GRANTED—
Aug 18, 2021EXT3SOU EXTENSION 3 FILED—
Aug 18, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 12, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 10, 2020EX2GSOU EXTENSION 2 GRANTED—
Dec 10, 2020EXT2SOU EXTENSION 2 FILED—
Dec 10, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 15, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 13, 2020EX1GSOU EXTENSION 1 GRANTED—
Aug 13, 2020EXT1SOU EXTENSION 1 FILED—
Aug 13, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 18, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 24, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 24, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 4, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 18, 2019ALIEASSIGNED TO LIE—
Nov 14, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 14, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Nov 14, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 14, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 14, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 14, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2019DOCKASSIGNED TO EXAMINER—
Aug 26, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 13, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance